Itepekimab is a fully human monoclonal antibody that binds to and inhibits interleukin-33 (IL33), an initiator and amplifier of broad inflammation in COPD. IL33 is thought to be involved in different ...

AERIFY-1 trial met the primary endpoint of a statistically significant reduction in moderate or severe exacerbations in former smokers rega ...

VICTOR is Professor of Innovation and Public Policy at the School of Global Policy and Strategy at the University of ...

PARIS, France and TARRYTOWN, NY, USA I May 30, 2025 I The AERIFY-1 phase 3 study evaluating itepekimab in former smokers with inadequately controlled chronic ...

The same cannot be said of the sweeping attack on human knowledge and progress that the Trump administration is now ...

A recent study reveals that sleep isn’t a luxury but a vital component of heart health. Even a few nights of poor rest can ...

A newly published study in Nature's Scientific Reports finds that use of ExThera's Seraph® 100 blood filter in septic patients following cardiac surgery significantly improved outcomes by rapidly ...

Awareness Month, which seeks to raise recognition and push for research of this rare genomic imprinting disorder. PWS is estimated to affect about one in 20 000 individuals1 yet, until now, people ...

A cancer biologist explains the broad harmful effects of alcohol on your health, and how it is the third-leading preventable ...

With the new Proteograph workflow, Seer achieves a transformative milestone by significantly improving the scalability, reproducibility, and affordability of deep proteomic analysis. These ...

The landscape of neurology biomarkers has evolved significantly in recent years, affording new clinical insights that are ...

The Brazilian Reproducibility Initiative team could replicate less than half of regional research findings. How can ...